Form 4: Syra Health Corp CFO Priya Prasad Reports Multiple Transactions in Company Stock
SEC Form 4
CFO and COO of Syra Health Corp, Priya Prasad, reports a series of acquisitions and disposals of Class A Common Stock and related warrants, including covering profits from short-swing transactions.
Summary
- Priya Prasad, CFO and COO of Syra Health Corp, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- The report includes multiple purchases and sales of Class A Common Stock between September 2023 and September 2024.
- Some transactions were made by Prasad's spouse, including purchases of units consisting of common stock and warrants.
- Prasad also reported transactions that are matchable under Section 16(b) of the Securities Exchange Act of 1934 and has paid the issuer approximately $8,577 to cover profits from these short-swing transactions.
- As of the latest transaction on September 12, 2024, Prasad indirectly owns 10,295 shares of Class A Common Stock.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative due to the reported short-swing transactions requiring repayment of profits, which raises minor compliance concerns. The multiple purchases could be seen as positive, but the sales offset this.
Negatives
- The report indicates that certain transactions are matchable under Section 16(b) of the Securities Exchange Act of 1934, suggesting potential short-swing profit liabilities.
- The CFO had to pay the issuer approximately $8,577 to cover profits from these short-swing transactions.
Risks
- The reported transactions raise potential concerns about compliance with insider trading regulations.
- Continued scrutiny of insider transactions could lead to further regulatory inquiries.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. The frequency and nature of these transactions can be scrutinized by investors for insights into management's view of the company's prospects.
Comparison to Industry Standards
- Monitoring insider trading activity is a standard practice in the financial industry.
- Comparing the trading patterns of Syra Health Corp's executives with those of executives at comparable healthcare technology companies can provide insights into relative valuation and sentiment.
- Companies like Teladoc Health and Cerner (now Oracle Health) are examples of companies where insider trading activity is closely watched.
Related Party Transactions
- The transactions made by Priya Prasad's spouse are considered related-party transactions and are disclosed in the report.
Stakeholder Impact
- Shareholders may scrutinize these transactions for insights into management's confidence in the company.
- The repayment of short-swing profits has a negligible impact on the company's financials.
Key Dates
| Date | Description |
|---|---|
| 09/29/2023 | Initial transaction date for reported purchases of Class A Common Stock. |
| 10/03/2023 | Purchase of 2,400 units, each including one share of Class A Common Stock and one warrant. |
| 10/05/2023 | Sale of 918 shares of Class A Common Stock. |
| 10/09/2023 | Purchase of 1,000 shares of Class A Common Stock. |
| 12/01/2023 | Purchase of 435 shares of Class A Common Stock. |
| 12/04/2023 | Purchase of 4,271 shares and sale of 735 shares of Class A Common Stock. |
| 12/05/2023 | Purchase of 10 shares and sale of 2,000 shares of Class A Common Stock. |
| 12/06/2023 | Purchase of 50 shares of Class A Common Stock. |
| 12/07/2023 | Purchase of 10 shares of Class A Common Stock. |
| 12/08/2023 | Purchase of 50 shares of Class A Common Stock. |
| 12/21/2023 | Purchase of 1 share of Class A Common Stock. |
| 02/08/2024 | Sale of 500 shares of Class A Common Stock. |
| 09/12/2024 | Purchase of 5,303 shares of Class A Common Stock. |
| 09/13/2024 | Date of signature for the Form 4 filing. |
| 10/03/2028 | Expiration date for warrants purchased on 10/03/2023. |
Keywords
Form 4, insider trading, beneficial ownership, Priya Prasad, Syra Health Corp, SYRA, Class A Common Stock, warrants, short-swing transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.